Other than skin cancer, prostate cancer is the most frequently diagnosed cancer in men, and it is the second leading cause of cancer-related death for males in the United States. This session explores the debate in screening policies between PSCI (Penn State cancer institute) and PSH.

Presenter Dr. Eugene “Gene” Lengerich, Professor of Public Health Sciences;  Director of the Office for Cancer Health Equity, and Associate Director for the Penn State Cancer Institute’s Health Disparities and Engagement; and Director, Public Health Preparedness Option, Master of Professional Studies in Homeland Security and Graduate Certificate, The Pennsylvania State University, provides an overview of the policies and practices of prostate cancer screening.

Register for this session here.